Aligos Therapeutics, Inc. announced that Leonid Beigelman resigned from the Board of Directors and from his position as President of the Company, effective as of December 1, 2023. Dr. Beigelman?s resignation is not related to any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7302 USD | -5.96% | -9.86% | +9.97% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.97% | 60.65M | |
+18.19% | 47.02B | |
+48.77% | 41.86B | |
+1.13% | 41.76B | |
-4.27% | 28.8B | |
+11.27% | 26.05B | |
-21.14% | 19.15B | |
+4.92% | 12.55B | |
+27.41% | 12.34B | |
-3.88% | 11.82B |
- Stock Market
- Equities
- ALGS Stock
- News Aligos Therapeutics, Inc.
- Aligos Therapeutics, Inc. Announces Executive Changes